Edwards Lifesciences to buy heart device maker for $400 mln

July 10 (Reuters) - Edwards Lifesciences Corp said it would buy privately held heart device maker CardiAQ Valve Technologies Inc for up to $400 million to expand its portfolio of less-invasive mitral valve replacement devices.